SCHEMBL7860609

SCHEMBL7860609

CCN1C(=O)/C(=C/c2ccc(-c3cccs3)s2)SC1=S

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TNFRSF1A P19438 1/20 0.55
▸ FFAR1 O14842 2/20 0.47
▸ ALDH1A1 P00352 6/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ MAPT P10636 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ LMNA P02545 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ IDE P14735 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ TNNI3 P19429 1/20 0.46
▸ TNNT2 P45379 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ TNNC1 P63316 1/20 0.46
▸ DPP4 P27487 1/20 0.45
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25165760 0.89 TNFRSF1A (0.62) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL1901692 0.85 PTPN22 (0.61) FFAR1ALDH1A1MEN1MAPTKMT2A
SCHEMBL1901690 0.85 PTPN22 (0.61) FFAR1ALDH1A1MEN1MAPTKMT2A
SCHEMBL1901689 0.85 PTPN22 (0.61) FFAR1ALDH1A1MEN1MAPTKMT2A
SCHEMBL6791506 0.83 FFAR1 (0.65) FFAR1ALDH1A1MEN1MAPTKMT2A
SCHEMBL3135714 0.83 TNFRSF1A (0.57) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL3135706 0.83 TNFRSF1A (0.57) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL3135718 0.83 TNFRSF1A (0.57) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL25165309 0.80 TNFRSF1A (0.59) TNFRSF1AALDH1A1MEN1MAPTKMT2A
SCHEMBL7859609 0.73 TNFRSF1A (0.49) TNFRSF1AALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 TNFRSF1A 212/4885FFAR1 3863/4885ALDH1A1 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback